INTRODUCTION {#sec1-1}
============

The number of individuals with diabetes is increasing daily, and diabetes is presently estimated to affect about 422 million adults worldwide.\[[@ref1]\] Diabetes is associated with liver cirrhosis, inflammation, apoptosis, and microvascular and macrovascular complications of the liver.\[[@ref2]\] This is linked with significant increase in inflammatory cytokines C-reactive protein, interleukin-1 (IL-1), interleukin 6 (IL 6), tumor necrotic factor-alpha (TNF-α), and chemokine monocyte chemotactic protein-1 (MCP-1). Reports have shown hyperglycemic effects from uncontrolled hepatic glucose output and reduced glucose uptake by skeletal muscle coupled with reduced glycogen synthesis.\[[@ref3]\] Moreover, there is increasing evidence from experimental and clinical studies indicating oxidative stress as a major player in diabetic pathophysiology leading to dyslipidemia, impaired glucose tolerance, β-cell dysfunction, and ultimately resulting to liver malfunction.\[[@ref4][@ref5]\] Conventional drugs metformin and glimepiride are used to treat diabetes but with severe side effects, lack of accessibility, and affordability while unconventional therapy is known to play significant roles in treating and managing diabetes with minimal side effects.\[[@ref6][@ref7]\] In diabetic state, there is increased generation of reactive oxygen species (ROS) which triggers a chain of reaction leading to the peroxidation of lipids, lipoprotein modifications, and several cellular mutations of biomolecules.\[[@ref8][@ref9]\] This effect leads to oxidative stress which is an important risk factor in the pathogenesis of cardiovascular and chronic diseases such as diabetic and associated complications.\[[@ref10]\]

*Moringa oleifera* (MO) is the most cultivated species of the Moringaceae family.\[[@ref11]\] It has been reported in folk medicine for its use in the treatment and management of diabetes.\[[@ref12]\] Interestingly, studies have shown that MO leaves are rich sources of antioxidant due to the the presence of various phytochemicals such as polyphenolics, carotenoids, α-tocopherol, ascorbic acid, and several amino acids.\[[@ref13][@ref14][@ref15]\] The bioavailability of these metabolites in MO has been directly linked to various biological profiles, especially its scavenging activity which helps ameliorate the damaging effects caused by oxidative stress in diabetic rats.\[[@ref16][@ref17][@ref18]\] Other notable metabolites with medicinal importance from the extracts of MOleaves include glycosides such as niazirin, niazirinin, niaziminin A and B, and 4-(alpha-1-rhamnopyranosyloxy)-benzylglucosinolate.\[[@ref19][@ref20][@ref21][@ref22]\] Scientists have reported the potency of various parts of this plant in animal model for their medicinal properties such as antidiabetic, analgesic, antiviral, antiulcer, anti-inflammatory, anticancer, antimicrobial, antioxidant, antifertility, cardioprotective, anticonvulsant, antiallergic, and antihelminthic activities.\[[@ref23][@ref24][@ref25][@ref26]\] These biological and pharmacological activities may help reduce cell death and cell proliferation. Sreelatha *et al*.\[[@ref27]\] reported antiproliferative effect of MOleaf extract on human cancer cells. MO has also been reported to elicit hepatoprotective properties in rats.\[[@ref28][@ref29]\]

Previous scientific reports on MO in the treatment of diabetes are limited in scope and do not extensively elucidate its action in the liver; hence, the need for this study to examine specific alterations in the liver and elucidate the hepatoprotective, anti-inflammatory, and lipid-lowering effects of MO in diabetic and nondiabetic male Wistar rats.

MATERIALS AND METHODS {#sec1-2}
=====================

Animal care {#sec2-1}
-----------

Healthy male adult Wistar strain rats weighing between 200 and 250 g were purchased from Charles River (Margate, UK) and housed at the Primate Unit, Stellenbosch University (Tygerberg Campus, South Africa) where animal treatment took place. For the duration of the study, the rats were housed in stainless steel cages of five rats per cage in a temperature-controlled animal facility of 22°C ± 2°C and humidity 55% ± 5% with alternating 12 h light/12 h dark cycles. The rats had access to fresh water and standard rat chow (SRC) from Aquanutro, Malmesbury, South Africa *ad libitum*.

Ethical approval {#sec2-2}
----------------

The study received approval from the Faculty of Health and Wellness Sciences, Research Ethics Committee of Cape Peninsula University of Technology, South Africa (CPUT/HW-REC 2014/AO8). All animals in the study received humane care according to the principles of laboratory animal care of the National Institutes of Health Guide for the care and use of laboratory animals of the National Academy of Science and published by the National Institutes of Health (publication no. 80--23, revised 1978).

Plant material {#sec2-3}
--------------

MOfresh leaves were collected and identified by Mr A.A. Adeyemo of the Forestry Research Institute of Nigeria. A voucher specimen was deposited in the herbarium with specimen number FHI-110287. MO leaves were washed with water, dried, and pulverized. The leaf powder was extracted with n-hexane, and dried marc was extracted with methanol at 45°C for 24 h. The filtrate was filtered using Whatman no. 1 filter paper and then evaporated in a rotatory evaporator under reduced pressure at 35°C. The methanolic extract was stored at −4°C until use.

Induction of diabetes {#sec2-4}
---------------------

Diabetes was induced in rats by injecting intraperitoneally, freshly prepared streptozotocin (STZ; 55 mg/kg body weight in 0.1 M cold citrate buffer, pH 4.5) according to the procedure of Jaiswal *et al*.\[[@ref18]\] Blood sample was collected from the rat tail, and fasting blood glucose level was measured using a glucometer (Accu-Check, Roche, Germany). The rats were considered diabetic when blood glucose level was ≥18 mmol/L. MO administration commenced on the 3^rd^ day after the rats were confirmed diabetic, and this was considered the 1^st^ day of treatment. The rats were randomly assigned into four groups of twelve rats (*n* = 12).

Experimental protocol {#sec2-5}
---------------------

Forty-eight rats were randomly divided into four groups as follows:

Group I: (Positive control) consisting of nondiabetic rats, which were treated with vehicle and SRC onlyGroup II: (*Moringa* treated + nondiabetic) nondiabetic-treated rats received only MO extract at a dose of 250 mg/kg and SRCGroup III: (Negative control) were diabetic and received the vehicle and SRC without receiving the plant extractGroup IV: (*Moringa* treated + diabetic) diabetic-treated rats received only MO extract at a dose of 250 mg/kg and SRC.

MO methanolic extract was dissolved in the vehicle and administered orally via oral gavage daily for 6 weeks to the treated groups while positive control groups and negative control groups received the vehicle and SRC daily for the duration of the study. The rats were weighed at the beginning of the experiment and weekly. At the end of study, animals were weighed, fasted overnight, and anesthetized intraperitoneally with sodium pentobarbital injection (60 mg/kg) to ensure rapid and painless death of rats.

Serum preparation {#sec2-6}
-----------------

Whole blood was collected from the rat\'s abdominal aorta into a serum clot activator tube. Serum was prepared by centrifugation at 4000 g for 10 min at 4°C and stored at −80°C for biochemical analysis.

Liver homogenate preparation {#sec2-7}
----------------------------

Liver was excised, rinsed in phosphate-buffered saline, and weighed, after which it was homogenized and centrifuged at 15,000 rpm for 10 min at 4°C and stored at −80°C for analysis.

Determination of weight parameter and glucose level {#sec2-8}
---------------------------------------------------

Liver weight was measured, and relative kidney weight was calculated by dividing the kidney weight by the total body weight. Glucose level was determined using kit from Randox Laboratories Limited (Crumlin, United Kingdom).

Analysis of liver enzymes activity {#sec2-9}
----------------------------------

Liver enzyme activities, namely, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP), were determined. AST activity is based on the reaction of α-oxoglutarate with L-aspartate to form oxaloacetate and L-glutamate. The oxaloacetate formed further reacts with NADH to form L-malate and NAD ^+^. ALT activity was estimated kinetically based on the reaction of α-oxoglutarate and L-alanine catalyzed by ALT to form L-glutamate and pyruvate. The indicator reaction used pyruvate for the kinetic estimation of NADH consumed. The pyruvate formed further reacts with NADH to form L-lactate. Measurement of ALP is based on the reaction of p-nitrophenyl phosphate which was hydrolyzed by ALP in the serum in the presence of magnesium ion to yield p-nitrophenol (yellow). The color intensity was proportional to the activity of ALP in the serum. The complex formed was measured at 405 nm. All protocols were followed according to the manufacturer\'s manual.

Determination of lipid profile levels {#sec2-10}
-------------------------------------

Lipid profiles such as low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol (CHOL) were analyzed. All assays were analyzed using diagnostic kits (Randox Crumlin, United Kingdom) using Randox Daytona automated analyzer (Randox Laboratories Limited, Crumlin, United Kingdom). Protocols were followed according to the manufacturer\'s standard operating procedures.

Antioxidant capacity {#sec2-11}
--------------------

Antioxidant capacity was measured in the liver by oxygen radical absorbance capacity (ORAC) assay according to the method of Ou *et al*.\[[@ref30]\] Values were expressed as μmol trolox equivalents/g tissue.

Analysis of inflammatory cytokines in the liver {#sec2-12}
-----------------------------------------------

The levels of inflammatory cytokines IL-6, MCP-1, and TNF-α were evaluated in the liver homogenates using MILLIPLEX ^®^ MAP rat cytokine magnetic bead-based Luminex kit (Merck Millipore, Billerica, MA, USA). Assays were performed strictly according to the manufacturer\'s protocol (Merck Millipore) and read on the Bio-plex ^®^ platform (Bio-Rad Laboratories, Hercules, CA, USA). The Bio-Plex Manager™ version 6.0 software was used for bead acquisition and analysis of median fluorescent intensities.

Histopathological analysis {#sec2-13}
--------------------------

The liver specimens excised from all experimental animals were washed and fixed in 10% buffered formalin. Tissues were processed by embedding in paraffin and sectioned (5 μm thickness). After deparaffinization, the paraffin blocks were stained with hematoxylin and eosin. The examination of stained slides and photomicrographing of slides was performed by a pathologist who was blinded to the study.

Statistical analysis {#sec2-14}
--------------------

Values are represented as mean ± standard deviation. GraphPad Prisms version 5.0 for Windows (San Diego, CA, USA) was used to analyze data using ANOVA with Bonferroni\'s multiple comparison test. *P* \< 0.05 was considered statistically significant.

RESULTS {#sec1-3}
=======

Effect of *Moringa oleifera* on weight parameters and serum glucose level {#sec2-15}
-------------------------------------------------------------------------

MO\'s effect on liver weight, relative liver weight, and serum glucose level are shown in [Table 1](#T1){ref-type="table"}. As shown in [Table 1](#T1){ref-type="table"}, the liver weight and the relative liver weight of animals injected with STZ were heavier compared to the NC, nondiabetic rats (positive control), MO, and nondiabetic-treated rats, respectively. However, significant (*P* \< 0.05) decrease in liver weight and relative liver weight was observed in MO-treated rats when compared to diabetic control group. Elevated serum glucose level decreased significantly (*P* \< 0.05) in groups administered with MO when compared to diabetic control.

###### 

Weight parameters and serum glucose level

![](PR-9-182-g002)

Hepatic enzyme activities {#sec2-16}
-------------------------

[Table 2](#T2){ref-type="table"} shows the activities of liver enzyme in nondiabetic rats and diabetic rats. From the results, a significant elevation in the activities of AST, ALT, and ALP in diabetic groups was observed when compared to nondiabetic rats (positive control). Treatment with MO led to a reduction in the activities of hepatic enzymes in all treated groups.

###### 

Hepatic enzyme activities

![](PR-9-182-g003)

Effect of *Moringa oleifera* on lipid profile and antioxidant capacity in the liver of rats {#sec2-17}
-------------------------------------------------------------------------------------------

[Table 3](#T3){ref-type="table"} illustrates the effect of MO on LDL, HDL, total CHOL, and antioxidant capacity in the liver of rats. Induction of diabetes with STZ elevated the level of LDL and CHOL in diabetic rats (negative control) when compared to nondiabetic rats (positive control). However, after the treatment of nondiabetic rats and diabetic rats with MO, LDL and CHOL levels reduced significantly compared to diabetic rats (negative control). HDL level increased significantly in nondiabetic-treated rats compared to nondiabetic and nontreated rats (positive control). There was no significant elevation (*P* \> 0.05) in the liver antioxidant capacity (ORAC) of MO-treated diabetic rats compared to the negative control but significantly increased (*P* \< 0.05) in nondiabetic-treated rats when compared to the positive control.

###### 

Lipid profile and antioxidant capacity in the liver of rats

![](PR-9-182-g004)

*Moringa oleifera* effect on inflammatory biomarkers in the liver of diabetic and nondiabetic rats {#sec2-18}
--------------------------------------------------------------------------------------------------

[Figure 1a](#F1){ref-type="fig"}--[c](#F1){ref-type="fig"} illustrates MOprotective effect on inflammatory biomarkers in the liver of diabetic and nondiabetic rats. Concentrations of inflammatory cytokines IL-6, TNF-α, and chemokine MCP-1 were elevated in diabetic groups. MO\'s treatment reduced significantly (*P* \< 0.05) inflammatory cytokines in the liver of diabetic rats.

![(a-c) Effect of *Moringa oleifera* on hepatic inflammatory biomarkers in diabetic and nondiabetic rats. Each bar represents mean (standard deviation) of 12 rats. ^a^*P* \< 0.05 values are significant compared with nondiabetic control. ^b^*P* \< 0.05 values are significant compared with diabetic control. NC: Nondiabetic rats (positive control), MO: Nondiabetic-treated rats; DM: Diabetic rats (negative control), DM + MO: Diabetic-treated rats](PR-9-182-g005){#F1}

Histopathological effect of *Moringa oleifera* on the hepatic structure of rats {#sec2-19}
-------------------------------------------------------------------------------

Histopathological liver specimens in nondiabetic-treated rats showed no visible lesions when compared to nondiabetic control \[[Figure 2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}\]. In diabetic rats, liver pathology revealed severe hepatocyte necrosis (1) at the centrilobular zone with large focus of massive hemorrhage into the liver parenchyma showing undefined boundaries, (2) degenerating nucleus, and (3) when compared to the diabetic-treated rats as shown in [Figure 2c](#F2){ref-type="fig"}. After treating diabetic rats with MO, liver section showed moderate portal congestion and very mild periportal cellular reaction, an improvement \[[Figure 2d](#F2){ref-type="fig"}\].

![(a-d) Histopathological effect of *Moringa oleifera* on hematoxylin and eosin stained liver sections of nondiabetic and diabetic rats, (H and E, ×400). (a) Nondiabetic rats (positive control), (b) nondiabetic-treated rats, (c) diabetic rats (negative control), and (d) diabetic-treated rats](PR-9-182-g006){#F2}

DISCUSSION {#sec1-4}
==========

The liver plays a vital role in the regulation of carbohydrate metabolism. It supplies glucose to other organs that require glucose as energy source and is one of the organs affected by diabetes. Attention has recently been focused on the use of therapeutic agents from plant origin in the treatment and management of diabetes as a result of severe side effects of contemporary antidiabetic drugs.\[[@ref31]\] In this study, diabetes was induced by intraperitoneal injection of STZ which caused hepatotoxicity and damage in the liver of diabetic rats. Medicinal plants including MO have attracted attention for their therapeutic properties and diabetes management. The hepatoprotective, antihyperlipidemic, and anti-inflammatory action of MO as well as its ability to modulate hepatic enzymes and biochemical parameters were evaluated in diabetic-induced rats.

Glucose homeostasis (balance between insulin and glucagon to maintain a stable blood glucose level) is essential for the utilization of glucose by the liver, muscles, and adipose tissues.\[[@ref32]\] Excess glucose concentration causes hyperglycemia and liver damage. Antidiabetic and glucose-lowering effect of MO has been reported.\[[@ref33][@ref34]\] In this study, diabetic-induced condition led to an increased serum glucose level (hyperglycemia). MO treatment significantly reduced glucose level which indicated an improvement in impaired glucose metabolism. MO has high glucose-lowering effect and can be used as an antidiabetic component. Our study confirms glucose-lowering effect of MO as previously reported.\[[@ref35]\]

We investigated the functional activities of liver enzymes AST, ALT, and ALP which are markers of hepatic damage. AST is an important biomarker for the diagnosis of myocardial infarction and amino acid metabolism.\[[@ref36]\] We observed a significantly (*P* \< 0.05) higher activity of AST in serum of STZ-diabetic-induced rats. Administration of MO reduced the activity of this enzyme.\[[@ref37]\] Result suggests hepatic damage as shown by elevated AST activity.

ALT predominantly found in the liver is a biomarker for hepatocellular injury. Elevated level is seen in diabetic state. Results from the current study showed a significantly higher ALT activity in diabetic groups when compared to nondiabetic-treated rats. The reduction of ALT concentration after MO treatment as seen in this study confirms observation by Fakurazi *et al*.\[[@ref29]\]

Increased activity of ALP is indicative of bile ducts obstruction and a biomarker for hepatic damage. ALP activity in diabetic groups was significantly elevated. Treatment with MO resulted in a significant reduction in ALP activity in diabetic rats compared to diabetic control, confirming previous studies.\[[@ref38][@ref39]\] These enzyme activities (AST, ALT, and ALP) were elevated in nontreated diabetic group but reduced significantly in MO diabetic-treated group. Studies revealed that exposure to STZ increased serum biomarkers associated with hepatic damage. Protective action of Mo significantly reduced hepatic enzymes activities.

The liver plays a pivotal role in lipid metabolism. CHOL is essential in Vitamin D synthesis and hormone metabolism. Normal range is beneficial but when exceeded it becomes harmful to cellular integrity. Excess CHOL forms plaque in artery walls, narrowing it and reducing the rate of blood circulation leading to a condition known as arteriosclerosis.

In STZ-induced diabetic rats, CHOL levels were elevated. However, after treatment with MO, CHOL level was reduced significantly when compared to controls. Furthermore, CHOL level in nondiabetic-treated rats was reduced after MO administration. Our results are in agreement with Chumark *et al*.\[[@ref40]\] who reported hypolipidemic activity of MO leaves extracts, indicating that MO significantly lowered CHOL level. Manohar *et al*.\[[@ref41]\] also reported similar results in which MO caused reduction in serum CHOL level.

Lipoproteins help transfer lipids around the body in the extracellular fluid.\[[@ref42]\] LDL is synthesized in the liver by the action of lipolytic enzymes with increased concentrations leading to CHOL build-up in the arteries.\[[@ref43]\] High level of LDL was observed in diabetic rats when compared to nondiabetic rats. Interestingly, after treatment with MO, LDL levels of diabetic rats and nondiabetic rats reduced significantly when compared to the control. Many other studies have alluded to the fact that MOhas hypoglycemic and hypolipidemic effects which are in tandem with findings from this study.\[[@ref12][@ref44][@ref45]\]

HDL mediates the reverse transport of CHOL from the extrahepatic tissues to the liver where the CHOL is converted to bile acid and excreted.\[[@ref46]\] HDL level increased significantly in nondiabetic-treated rats compared to nondiabetic rats (positive control).

Treatment with MO led to an increase in liver antioxidant capacity (ORAC) when compared to control groups. ORAC of MO-treated diabetic liver was restored to near normal values. Similar study by Jaiswal *et al*.\[[@ref18]\] confirms this result.

The concentrations of three cytokines (IL-6, TNF-α) and one chemokine (MCP-1/CCL2) were quantified in the liver homogenate of diabetic and nondiabetic rats in the present study \[[Figure 1a](#F1){ref-type="fig"}--[c](#F1){ref-type="fig"}\]. Cytokines are messenger molecules of the immune system, mediating cellular movement among lymphocytes, macrophages, dendritic cells, and other inflammatory cells. Inflammation is one of the markers of oxidative stress. Generation of ROS leads to the upregulation of pro-inflammatory cytokines which have been reported in diabetic state in rats.\[[@ref47][@ref48]\] TNF-α activates endothelial cells attached to corresponding proteins and inflammatory responses. TNF-α has also been implicated in diabetic hepatic disease through diverse biological activities including impairment of insulin secretion and induction of apoptosis and necrosis.\[[@ref49][@ref50]\] MO has beneficial effects in various pathological conditions through its antioxidative and anti-inflammatory properties. Concentrations of IL-6, TNF-α, and MCP-1 increased significantly (*P* \< 0.05) in STZ-induced rats, and a decrease was observed after MO treatment compared to diabetic control. As a result of MO\'s potent anti-inflammatory activity, it can be said to show profound influence on inflammatory-associated diseases and resultant symptoms. On the basis of our study, it can be postulated that MOcan exert its hepatoprotective effect and anti-inflammatory action against these cytokines and chemokine.

The present study demonstrates STZ-induced hepatotoxicity and that the liver and relative liver weights of diabetic rats were heavier compared to nondiabetic groups. However, after administration of MO to nondiabetic and diabetic rats, a decrease in liver and relative weights was observed. Increase in both weights in diabetic rats may be due to enlargement of tubular cells lining and fatty infiltration of the liver.\[[@ref51]\]

Histopathological sections of the liver are shown in [Figure 2a](#F2){ref-type="fig"}--[d](#F2){ref-type="fig"}. Nondiabetic-treated rats showed no visible lesions when compared to nondiabetic control \[[Figure 2a](#F2){ref-type="fig"} and [b](#F2){ref-type="fig"}\]. Liver specimens from diabetic rats revealed severe hepatocyte necrosis at the centrilobular zone with large focus of massive hemorrhage into the liver parenchyma, with undefined boundaries when compared to the diabetic-treated rats as shown in [Figure 2c](#F2){ref-type="fig"}. This may have accounted for the increase in the weight of the liver. After treatment of diabetic rats with MO, liver section showed moderate portal congestion and very mild periportal cellular reaction \[[Figure 2d](#F2){ref-type="fig"}\]. MO treatment restored the normal histology of the liver compared to that of the diabetic-positive control group, and this was corroborated by similar previous study.\[[@ref52]\] Furthermore, histological section showed severe hepatocyte necrosis in the liver of the diabetic rats which were cleared in MO-treated diabetic rats.

The main limitation of our study was identifying the specific metabolic pathway for the action of MO. Further studies to investigate the metabolic action of MOin the liver are recommended.

CONCLUSIONS {#sec1-5}
===========

MO methanolic leaves extracts showed hepatoprotective, anti-inflammatory, and lipid-lowering effect against hyperglycemia and liver damage induced by STZ in rats. MO may be able to lower the risk of cardiovascular diseases with its ability to lower the levels of CHOL and LDL but increase HDL.
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